subject: CHEBI:72296

subject_name: Apixaban

object_name: ANTICOAGULATION (finding)


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: engraftment syndrome

tested_intervention: unsure


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine

object_name: nonpapillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:4739

object_name: clear cell renal carcinoma


subject: PUBCHEM.COMPOUND:4739

object_name: renal cell adenocarcinoma


subject: PUBCHEM.COMPOUND:4739


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:27834

subject_name: Pentostatin


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:7421

subject_name: NAC

object_name: Huntington disease


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:4445

subject_name: Desflurane

object_name: obesity due to melanocortin 4 receptor deficiency

tested_intervention: yes


subject: CHEBI:4445

object_name: Obesity, CTCAE


subject: CHEBI:4445

object_name: Arthritis, CTCAE


subject: CHEBI:44915

subject_name: Propofol


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C4723695

subject_name: penpulimab

object_name: Childhood Solid Neoplasm


subject: UMLS:C4723695

object_name: Adult Solid Neoplasm


subject: UMLS:C4723695

object_name: Solid Neoplasm


subject: UMLS:C4723695

object_name: Klatskin Tumor


subject: UMLS:C5554951

subject_name: Bcl-2 Inhibitor ZN-d5

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5554951

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C5554951

object_name: Childhood Non-Hodgkin Lymphoma


subject: GTOPDB:10492

subject_name: envafolimab


subject: GTOPDB:10492


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UMLS:C4683552

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UMLS:C4683552

object_name: metastatic melanoma


subject: CHEBI:32682

subject_name: L-argininium

object_name: pneumonia


subject: CHEBI:32682

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:6121

subject_name: Ketamine

object_name: Tobacco user


subject: CHEBI:6121

object_name: Tobacco use history


subject: CHEBI:6121

object_name: Encounter due to tobacco use


subject: CHEBI:6121

object_name: nicotine dependence


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: amenorrhea


subject: PUBCHEM.COMPOUND:21628493

object_name: Amenorrhea, CTCAE


subject: PUBCHEM.COMPOUND:21628493

object_name: Osteopenia


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: CHEBI:50114


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: UMLS:C2936882


subject: UMLS:C2936882


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: acute biphenotypic leukemia


subject: UNII:D7RD81HE4W

object_name: mixed phenotype acute leukemia


subject: UNII:D7RD81HE4W

object_name: acute leukemia of ambiguous lineage


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: PUBCHEM.COMPOUND:3367

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:3367

object_name: Pathologic Stage IIIB Cutaneous Melanoma AJCC v8


subject: PUBCHEM.COMPOUND:3367

object_name: Pathologic Stage IIID Cutaneous Melanoma AJCC v8


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: DRUGBANK:DB17107

subject_name: Lifileucel


subject: DRUGBANK:DB17107

object_name: Locally Advanced Melanoma


subject: DRUGBANK:DB17107


subject: DRUGBANK:DB17107


subject: UNII:0T0250N43U

subject_name: peginterferon lambda-1a


subject: UMLS:C4043002


subject: CHEBI:3441

subject_name: Carvedilol

object_name: prostate carcinoma


subject: CHEBI:3441

object_name: prostate cancer


subject: DRUGBANK:DB10769

subject_name: Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)

object_name: Immunization reaction


subject: DRUGBANK:DB10769

object_name: Vaccine-Preventable Diseases


subject: UMLS:C0771080

subject_name: Japanese Encephalitis Vaccines


subject: UMLS:C0771080


subject: UMLS:C3714691

subject_name: Japanese B encephalitis vaccine (product)


subject: UMLS:C3714691


subject: UNII:7UQ7X4Y489

subject_name: TINZAPARIN

object_name: thrombophilia, X-linked, due to factor 9 defect


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UMLS:C2703099

object_name: skin melanoma


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Leptomeningeal Neoplasms


subject: UNII:KXG2PJ551I

object_name: neoplastic meningitis


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: PUBCHEM.COMPOUND:137706467

subject_name: Rimiducid

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:137706467

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: thyroid gland undifferentiated (anaplastic) carcinoma


subject: UNII:6QVL057INT

object_name: BRAF mutation-related tumors


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib


subject: PUBCHEM.COMPOUND:139350422


subject: UMLS:C5205927


subject: UMLS:C5205927

object_name: thyroid tumor


subject: UMLS:C5205927

object_name: thyroid gland carcinoma


subject: UMLS:C5205927

object_name: thyroid cancer


subject: UMLS:C5205927


subject: UNII:1P05PW62F3

subject_name: CONBERCEPT

object_name: Polypoidal choroidal vasculopathy


subject: UMLS:C2352201

subject_name: Conbercept


subject: UMLS:C5554607

subject_name: Obrixtamig

object_name: small cell lung carcinoma


subject: UMLS:C5554607

object_name: Extrapulmonary Neuroendocrine Carcinoma


subject: CHEBI:28001

subject_name: Vancomycin

object_name: Catheter related infection


subject: CHEBI:41001

subject_name: Benzoylecgonine

object_name: type 1 diabetes mellitus 1


subject: CHEBI:41001

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: PUBCHEM.COMPOUND:251912


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C2698319


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: UMLS:C0004886


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: PR:000002994


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: carotid stenosis


subject: UMLS:C0388020

subject_name: Gadovist


subject: UMLS:C2713023


subject: DRUGBANK:DB16341

subject_name: Tilsotolimod

object_name: Advanced cancer


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Non-small cell lung cancer stage III


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: chronic graft versus host disease


subject: UMLS:C1541395


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE


subject: UNII:GN429E725A

subject_name: Nedisertib

object_name: Refractory acute myeloid leukemia


subject: UNII:GN429E725A


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: insomnia


subject: PUBCHEM.COMPOUND:4715169

object_name: Insomnia, CTCAE 3.0


subject: PUBCHEM.COMPOUND:4715169

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:6801

subject_name: Metformin

object_name: outcomes general quality of life


subject: CHEBI:6801

object_name: Perceived quality of life


subject: CHEBI:6801

object_name: Good quality of life


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Fabry disease


subject: UNII:H18SKU3289

subject_name: visilizumab

object_name: Crohn disease


subject: UMLS:C1135148

subject_name: Nuvion


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: B-cell small lymphocytic lymphoma stage I


subject: UNII:3A58010674

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UNII:3A58010674

object_name: nodal marginal zone B-cell lymphoma


subject: UNII:3A58010674

object_name: Marginal zone lymphoma stage I


subject: UNII:3A58010674

object_name: splenic marginal zone lymphoma


subject: UNII:3A58010674

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:3A58010674

object_name: B-cell small lymphocytic lymphoma stage III


subject: UNII:3A58010674

object_name: Marginal zone lymphoma stage IV


subject: UNII:3A58010674

object_name: Marginal zone lymphoma recurrent


subject: UNII:3A58010674

object_name: Marginal zone lymphoma stage III


subject: UNII:3A58010674

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UNII:3A58010674

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:3A58010674

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: UNII:3A58010674

object_name: MALT lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: UNII:3A58010674

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Hypervolemia


subject: PUBCHEM.COMPOUND:137319706

subject_name: Orforglipron

object_name: cardiovascular disorder


subject: UNII:7ZW40D021M

subject_name: ORFORGLIPRON


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Femoral hernia


subject: UNII:KIB8V5UR7D

subject_name: Elismetrep

object_name: Acute migraine


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Verruca plana


subject: CHEMBL.COMPOUND:CHEMBL4297812

object_name: asthma


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Hodgkin Disease


subject: CHEBI:66964

subject_name: Dronabinol

object_name: opiate dependence


subject: CHEBI:33390

subject_name: curium atom

object_name: childhood onset asthma


subject: MESH:C084136

subject_name: liu-jun-zi-tang


subject: PUBCHEM.COMPOUND:54323514

subject_name: Dihydroxyphenyl-alanine

object_name: glioma


subject: PUBCHEM.COMPOUND:54323514

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:54395886

subject_name: (Dihydroxyphenyl)alanine


subject: PUBCHEM.COMPOUND:54395886


subject: UNII:6897GXD6OE

object_name: Fatigue, CTCAE 5.0


subject: UNII:6897GXD6OE

object_name: Fatigue


subject: UMLS:C0445115

subject_name: Normal saline


subject: UMLS:C0445115


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:52717

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:52717

object_name: Recurrent ovarian cancer


subject: CHEBI:52717

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: CHEBI:52717

object_name: fallopian tube clear cell adenocarcinoma


subject: CHEBI:52717

object_name: fallopian tube transitional cell carcinoma


subject: CHEBI:52717

object_name: fallopian tube serous adenocarcinoma


subject: CHEBI:52717

object_name: fallopian tube endometrioid adenocarcinoma


subject: CHEBI:52717

object_name: fallopian tube mucinous adenocarcinoma


subject: CHEBI:52717

object_name: ovarian Brenner tumor


subject: CHEBI:52717

object_name: ovarian transitional cell carcinoma


subject: CHEBI:52717

object_name: undifferentiated ovarian carcinoma


subject: CHEBI:52717

object_name: ovarian clear cell adenocarcinoma


subject: CHEBI:52717

object_name: ovarian clear cell cystadenocarcinoma


subject: CHEBI:52717

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:52717

object_name: ovarian seromucinous carcinoma


subject: CHEBI:52717

object_name: ovarian serous adenocarcinoma


subject: CHEBI:52717

object_name: Primary mucinous adenocarcinoma of ovary


subject: CHEBI:52717

object_name: ovarian mucinous adenocarcinoma


subject: CHEBI:52717

object_name: ovarian serous cystadenocarcinoma


subject: CHEBI:52717

object_name: ovarian mucinous cystadenocarcinoma


subject: UNII:WKM56H3TLB

subject_name: Myrcludex B

object_name: liver cirrhosis


subject: UNII:WKM56H3TLB

object_name: portal hypertension


subject: UNII:WKM56H3TLB

object_name: Portal Hypertension, CTCAE


subject: DRUGBANK:DB16341

subject_name: Tilsotolimod

object_name: melanoma


subject: PUBCHEM.COMPOUND:56841998

subject_name: Epoch

object_name: mantle cell lymphoma


subject: CHEBI:4672

subject_name: Docetaxel

object_name: male breast carcinoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: UMLS:C1258613

subject_name: oblimersen sodium


subject: UMLS:C1258613

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C1258613

object_name: Carcinoma breast stage IV


subject: UMLS:C1258613

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1258613

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1258613

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1258613

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1258613

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C1258613

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C1258613

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1258613

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1258613

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C1258613

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C1258613

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C1258613

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: colitis


subject: UNII:9RV78Q2002

object_name: Colitis, CTCAE


subject: UNII:9RV78Q2002

object_name: Genitourinary Cancer


subject: UNII:9RV78Q2002

object_name: non-small cell lung carcinoma


subject: UNII:9RV78Q2002

object_name: Malignant Solid Neoplasm


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: CHEBI:142825

subject_name: Methfuroxam

object_name: glioblastoma


subject: CHEBI:142825

object_name: Brain Stem Glioblastoma


subject: CHEBI:142825

object_name: glioma susceptibility 1


subject: UMLS:C0730719

subject_name: Trivax


subject: UMLS:C0730719


subject: UMLS:C0730719


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON

object_name: heart disorder


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson


subject: UNII:DYO3SU8O2M

object_name: hypertension


subject: UNII:DYO3SU8O2M

object_name: Hypertension, CTCAE


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Dental Plaque


subject: CHEBI:39548

object_name: Skin plaque


subject: CHEBI:39548

object_name: Senile plaques


subject: CHEBI:39548

object_name: Plaque (lesion)


subject: UNII:61S98RLL5I

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A

object_name: Congenital IGHD


subject: PUBCHEM.COMPOUND:16129681

object_name: Reduced circulating growth hormone concentration


subject: PUBCHEM.COMPOUND:16129681

object_name: acromegaly


subject: PUBCHEM.COMPOUND:16129681

object_name: Acral overgrowth


subject: PUBCHEM.COMPOUND:16129681

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:16129681

object_name: Diabetes


subject: PUBCHEM.COMPOUND:16129681

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:53481605

subject_name: Somatostatin


subject: PUBCHEM.COMPOUND:53481605


subject: PUBCHEM.COMPOUND:53481605


subject: PUBCHEM.COMPOUND:53481605


subject: PUBCHEM.COMPOUND:53481605


subject: PUBCHEM.COMPOUND:53481605


subject: PUBCHEM.COMPOUND:53481605


subject: CHEBI:70839

subject_name: Dasatinib

object_name: pancreatic adenocarcinoma


subject: CHEBI:70839

object_name: stage IV pancreatic cancer


subject: CHEBI:70839

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Adult bronchiectasis


subject: CHEBI:28864

subject_name: Tobramycin


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Disorder of Achilles tendon


subject: GTOPDB:9421

subject_name: itolizumab

object_name: acute respiratory distress syndrome


subject: GTOPDB:9421

object_name: adult acute respiratory distress syndrome


subject: UNII:XQQ2RHV14N


subject: UNII:XQQ2RHV14N


subject: UMLS:C2987424


subject: UMLS:C2987424


subject: UMLS:C0037766

subject_name: Antispasmodics

object_name: Biliary Colic


subject: UMLS:C0037766

object_name: cholecystitis


subject: UMLS:C0037766

object_name: acalculous cholecystitis


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:80961


subject: CHEBI:80961

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:80961


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:73579

subject_name: Leu-Val


subject: CHEBI:73579


subject: CHEBI:194537

subject_name: Livermorium


subject: CHEBI:194537


subject: UMLS:C1881413

subject_name: Liposome Vesicle


subject: UMLS:C1881413


subject: PR:000003915

subject_name: delta-aminolevulinic acid dehydratase


subject: PR:000003915


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:178199

subject_name: Sotorasib

object_name: pancreatic neoplasm


subject: CHEBI:178199

object_name: exocrine pancreatic carcinoma


subject: CHEBI:178199

object_name: malignant pancreatic neoplasm


subject: CHEBI:178199


subject: CHEBI:178199


subject: CHEBI:16576

subject_name: D-alanyl-D-alanine

object_name: Diabetes Mellitus, Experimental


subject: CHEBI:16576

object_name: type 1 diabetes mellitus 1


subject: CHEBI:16576

object_name: type 1 diabetes mellitus


subject: CHEBI:195181

subject_name: Alanylalanine


subject: CHEBI:195181


subject: CHEBI:195181


subject: UMLS:C0051078

subject_name: alanylalanine


subject: UMLS:C0051078


subject: UMLS:C0051078


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: osteoarthritis


subject: UMLS:C0146226

subject_name: Toradol


subject: GTOPDB:13792

subject_name: iparomlimab

object_name: ovarian carcinoma


subject: GTOPDB:13792

object_name: malignant epithelial tumor of ovary


subject: GTOPDB:13792

object_name: fallopian tube carcinoma


subject: GTOPDB:13792

object_name: fallopian tube cancer


subject: GTOPDB:13792

object_name: primary peritoneal carcinoma


subject: GTOPDB:13792

object_name: papillary serous cystadenocarcinoma


subject: GTOPDB:13792

object_name: peritoneal carcinoma


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UNII:FN3VWV28BC


subject: UNII:FN3VWV28BC


subject: UNII:FN3VWV28BC


subject: UNII:FN3VWV28BC


subject: UNII:FN3VWV28BC


subject: UNII:FN3VWV28BC


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: UMLS:C5669553


subject: UMLS:C5669553


subject: UMLS:C5669553


subject: UMLS:C5669553


subject: UMLS:C5669553


subject: UMLS:C5669553


subject: GTOPDB:13793

subject_name: tuvonralimab


subject: GTOPDB:13793


subject: GTOPDB:13793


subject: GTOPDB:13793


subject: GTOPDB:13793


subject: GTOPDB:13793


subject: GTOPDB:13793


subject: UNII:8XWO7LI4LO

subject_name: TUVONRALIMAB


subject: UNII:8XWO7LI4LO


subject: UNII:8XWO7LI4LO


subject: UNII:8XWO7LI4LO


subject: UNII:8XWO7LI4LO


subject: UNII:8XWO7LI4LO


subject: UNII:8XWO7LI4LO


subject: UMLS:C5784793

subject_name: Tuvonralimab


subject: UMLS:C5784793


subject: UMLS:C5784793


subject: UMLS:C5784793


subject: UMLS:C5784793


subject: UMLS:C5784793


subject: UMLS:C5784793


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: Recurrent Malignant Glioma


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: colorectal cancer


subject: UNII:R8DG7T2D3A

object_name: colorectal carcinoma


subject: UNII:R8DG7T2D3A

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:46726


subject: PUBCHEM.COMPOUND:13559282

subject_name: Ulipristal acetate

object_name: Injury of liver


subject: PUBCHEM.COMPOUND:13559282

object_name: Adverse effects


subject: CHEBI:71025

subject_name: ulipristal


subject: CHEBI:71025


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Moderate aortic valve stenosis


subject: UNII:CGA81G3KR5

subject_name: PUCOTENLIMAB

object_name: nasopharyngeal type undifferentiated carcinoma


subject: UNII:CGA81G3KR5

object_name: carcinoma


subject: UMLS:C5205493

subject_name: Pucotenlimab


subject: UMLS:C5205493


subject: UMLS:C4764320

subject_name: Bupropion HCl Extended Release

object_name: Depressed mood


subject: UNII:3ZY6J6Z6EE

subject_name: Droxidopa

object_name: Freezing of gait


subject: UNII:3ZY6J6Z6EE

object_name: INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1


subject: CHEBI:40799

subject_name: Boldione

object_name: Adenocarcinoma of the prostate metastatic


subject: CHEBI:40799

object_name: Prostate Carcinoma Metastatic in the Bone


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Immunity, Innate


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: diabetic neuropathy


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C1705207

subject_name: Endostar

object_name: metastatic colorectal cancer


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: severe traumatic brain injury


subject: CHEBI:46195

object_name: subarachnoid hemorrhage


subject: CHEBI:132922


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:31401

subject_name: Cilostazol

object_name: Variant Angina


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]

object_name: hypertriglyceridemia


subject: UMLS:C3536908

object_name: Hypertriglyceridemia, CTCAE


subject: UMLS:C3536908

object_name: type 2 diabetes mellitus


subject: CHEBI:51788

subject_name: faropenem

object_name: Community-Acquired Pneumonia


subject: CHEBI:3084

subject_name: Bethanechol


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: Stage IIIC Esophageal Cancer AJCC v7


subject: UNII:R8DG7T2D3A

object_name: Stage IIB Esophageal Carcinoma


subject: UNII:R8DG7T2D3A

object_name: Stage III Esophageal Cancer AJCC v7


subject: UNII:R8DG7T2D3A

object_name: Stage IIIA Esophageal Cancer AJCC v7


subject: UNII:R8DG7T2D3A

object_name: Stage IIIB Esophageal Cancer AJCC v7


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:46726


subject: PUBCHEM.COMPOUND:54214995

subject_name: Sacubitril

object_name: resistant hypertension


subject: PUBCHEM.COMPOUND:54214995

object_name: Hypertension resistant to conventional therapy


subject: CHEBI:9927

subject_name: Valsartan


subject: CHEBI:9927


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Advanced Clear Cell Renal Cell Carcinoma


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Clear-cell metastatic renal cell carcinoma


subject: CHEBI:166975

subject_name: soybean oil

object_name: Infection


subject: CHEBI:166975

object_name: Infection of musculoskeletal system


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: DRUGBANK:DB09422


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: total parenteral nutrition


subject: UMLS:C5556562

subject_name: Multi-kinase Inhibitor LNK01002

object_name: acquired polycythemia vera


subject: UMLS:C5556562

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5556562

object_name: acute myeloid leukemia


subject: UMLS:C5556562


subject: UMLS:C5556562

object_name: Post-polycythemia vera myelofibrosis


subject: UMLS:C5556562

object_name: myelofibrosis


subject: CHEBI:233453

object_name: immunodeficiency disease


subject: CHEBI:233453

object_name: inborn error of immunity


subject: CHEBI:35854

subject_name: Valaciclovir


subject: CHEBI:35854


subject: DRUGBANK:DB15572

subject_name: Exagamglogene autotemcel

object_name: sickle cell disease


subject: UNII:AVK0I6HY2U

subject_name: Abaloparatide

object_name: Femur fracture


subject: DRUGBANK:DB17587

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB17587

object_name: intrahepatic cholangiocarcinoma


subject: DRUGBANK:DB17587

object_name: urothelial carcinoma


subject: DRUGBANK:DB17587

object_name: transitional cell carcinoma


subject: DRUGBANK:DB16615

subject_name: Krill oil

object_name: Well adult


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Diabetic


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: PUBCHEM.COMPOUND:11306691

object_name: myocardial infarction


subject: PUBCHEM.COMPOUND:11306691

object_name: Myocardial Infarction, CTCAE


subject: PUBCHEM.COMPOUND:11306691

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:40237


subject: UMLS:C1310652

subject_name: Importal


subject: UMLS:C1310652


subject: UMLS:C1310652


subject: UMLS:C1310652


subject: CHEBI:8863

subject_name: Riluzole

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:8863

object_name: Embolism, Tumor


subject: CHEBI:8863

object_name: Neoplasm Metastasis


subject: CHEBI:8863

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:KX89J0DFZ8

subject_name: IMSIDOLIMAB

object_name: generalized pustular psoriasis


subject: UMLS:C0249056


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Impulsivity


subject: PUBCHEM.COMPOUND:3222

object_name: cardiotoxicity


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: type 1 diabetes mellitus


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: Recurrent Endometrial Cancer


subject: UNII:CWG62Q1VTB

object_name: Solid Neoplasm


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS


subject: UNII:71M78END5S

object_name: Hyperlipidemia, group A


subject: UNII:71M78END5S

object_name: Triglyceride storage Type I or II disease


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEMBL.COMPOUND:CHEMBL4650401

object_name: hypophosphatemic rickets, autosomal recessive, 2


subject: CHEMBL.COMPOUND:CHEMBL4650401

object_name: Arterial calcification


subject: UMLS:C5814286


subject: UMLS:C5814286


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:70839

subject_name: Dasatinib

object_name: interstitial lung disease 2


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: B-cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Indolent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Digestive System Signs and Symptoms


subject: PUBCHEM.COMPOUND:11654566

object_name: Absence of Signs or Symptoms


subject: UMLS:C3539881

subject_name: gamma-interferon

object_name: myxoid liposarcoma


subject: UMLS:C3539881

object_name: round cell liposarcoma


subject: UMLS:C3539881

object_name: Childhood Synovial Sarcoma


subject: UMLS:C3539881

object_name: Adult Synovial Sarcoma


subject: UMLS:C3539881

object_name: synovial sarcoma


subject: UMLS:C3539881

object_name: myxoid/round cell liposarcoma


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: impotence


subject: CHEBI:47519

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:47519

object_name: Erectile dysfunction


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:45409


subject: CHEBI:45409


subject: CHEBI:31859

subject_name: Modafinil

object_name: Weight Gain


subject: CHEBI:31859

object_name: Weight Gain, CTCAE


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: neuroendocrine neoplasm


subject: UNII:M89N0Q7EQR

object_name: plasma cell myeloma


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: MESH:C000730996

object_name: chronic kidney disease


subject: CHEBI:2453

subject_name: Acyclovir

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:2453

object_name: Adult L1 Acute Lymphoblastic Leukemia


subject: CHEBI:2453

object_name: Adult L2 Acute Lymphoblastic Leukemia


subject: CHEBI:2453

object_name: Childhood L2 Acute Lymphoblastic Leukemia


subject: CHEBI:2453

object_name: Childhood L1 Acute Lymphoblastic Leukemia


subject: CHEBI:2453

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:2453

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:2453

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:2453

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:2453

object_name: Untreated Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:2453

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:2453

object_name: acute undifferentiated leukemia


subject: CHEBI:2453

object_name: Philadelphia chromosome negative adult precursor acute lymphoblastic leukemia


subject: CHEBI:2453

object_name: Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia


subject: CHEBI:2453

object_name: Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: UNII:3A189DH42V

subject_name: Alemtuzumab


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: UNII:3A189DH42V


subject: CHEBI:40279

subject_name: Allopurinol


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:32660

subject_name: asparaginase


subject: CHEBI:32660


subject: CHEBI:32660


subject: CHEBI:32660


subject: CHEBI:32660


subject: CHEBI:32660


subject: CHEBI:32660


subject: CHEBI:32660


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:94265


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41977


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:45783

subject_name: Imatinib


subject: CHEBI:45783


subject: CHEBI:45783


subject: CHEBI:45783


subject: CHEBI:45783


subject: CHEBI:45783


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:3770

subject_name: co-trimoxazole


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: CHEBI:3770


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: UNII:3S9RX35S5X

subject_name: Fimepinostat

object_name: differentiated thyroid carcinoma


subject: UNII:3S9RX35S5X

object_name: thyroid tumor


subject: MESH:C477385

subject_name: montanide ISA 51

object_name: mixed glioma


subject: MESH:C477385

object_name: Adult Mixed Glioma


subject: MESH:C477385

object_name: Childhood Mixed Glioma


subject: MESH:C477385

object_name: Adult Giant Cell Glioblastoma


subject: MESH:C477385

object_name: Childhood Giant Cell Glioblastoma


subject: MESH:C477385

object_name: giant cell glioblastoma


subject: MESH:C477385

object_name: Childhood Anaplastic Oligodendroglioma


subject: MESH:C477385

object_name: anaplastic oligodendroglioma


subject: MESH:C477385

object_name: Adult Anaplastic Oligodendroglioma


subject: MESH:C477385

object_name: Childhood Anaplastic Oligoastrocytoma


subject: MESH:C477385

object_name: anaplastic oligoastrocytoma


subject: MESH:C477385

object_name: Recurrent Adult Brain Neoplasm


subject: MESH:C477385

object_name: Recurrent Childhood Brain Neoplasm


subject: MESH:C477385

object_name: Recurrent Brain Neoplasm


subject: MESH:C477385

object_name: Grade III Childhood Astrocytoma


subject: MESH:C477385

object_name: Adult Anaplastic Astrocytoma


subject: MESH:C477385

object_name: anaplastic astrocytoma


subject: MESH:C477385

object_name: glioblastoma


subject: MESH:C477385

object_name: Childhood Glioblastoma


subject: MESH:C477385

object_name: adult glioblastoma


subject: MESH:C477385

object_name: Adult Gliosarcoma


subject: MESH:C477385

object_name: gliosarcoma


subject: MESH:C477385

object_name: Childhood Gliosarcoma


subject: UMLS:C1708275

subject_name: HLA-A1, A2, B35-Restricted Survivin Peptides/Montanide ISA-51 Vaccine

object_name: mixed glioma


subject: UMLS:C1708275

object_name: Adult Mixed Glioma


subject: UMLS:C1708275

object_name: Childhood Mixed Glioma


subject: UMLS:C1708275

object_name: Adult Giant Cell Glioblastoma


subject: UMLS:C1708275

object_name: Childhood Giant Cell Glioblastoma


subject: UMLS:C1708275

object_name: giant cell glioblastoma


subject: UMLS:C1708275

object_name: Childhood Anaplastic Oligodendroglioma


subject: UMLS:C1708275

object_name: anaplastic oligodendroglioma


subject: UMLS:C1708275

object_name: Adult Anaplastic Oligodendroglioma


subject: UMLS:C1708275

object_name: Childhood Anaplastic Oligoastrocytoma


subject: UMLS:C1708275

object_name: anaplastic oligoastrocytoma


subject: UMLS:C1708275

object_name: Recurrent Adult Brain Neoplasm


subject: UMLS:C1708275

object_name: Recurrent Childhood Brain Neoplasm


subject: UMLS:C1708275

object_name: Recurrent Brain Neoplasm


subject: UMLS:C1708275

object_name: Grade III Childhood Astrocytoma


subject: UMLS:C1708275

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C1708275

object_name: anaplastic astrocytoma


subject: UMLS:C1708275

object_name: glioblastoma


subject: UMLS:C1708275

object_name: Childhood Glioblastoma


subject: UMLS:C1708275

object_name: adult glioblastoma


subject: UMLS:C1708275

object_name: Adult Gliosarcoma


subject: UMLS:C1708275

object_name: gliosarcoma


subject: UMLS:C1708275

object_name: Childhood Gliosarcoma


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: mixed glioma


subject: UNII:5TAA004E22

object_name: Adult Mixed Glioma


subject: UNII:5TAA004E22

object_name: Childhood Mixed Glioma


subject: UNII:5TAA004E22

object_name: Adult Giant Cell Glioblastoma


subject: UNII:5TAA004E22

object_name: Childhood Giant Cell Glioblastoma


subject: UNII:5TAA004E22

object_name: giant cell glioblastoma


subject: UNII:5TAA004E22

object_name: Childhood Anaplastic Oligodendroglioma


subject: UNII:5TAA004E22

object_name: anaplastic oligodendroglioma


subject: UNII:5TAA004E22

object_name: Adult Anaplastic Oligodendroglioma


subject: UNII:5TAA004E22

object_name: Childhood Anaplastic Oligoastrocytoma


subject: UNII:5TAA004E22

object_name: anaplastic oligoastrocytoma


subject: UNII:5TAA004E22

object_name: Recurrent Adult Brain Neoplasm


subject: UNII:5TAA004E22

object_name: Recurrent Brain Neoplasm


subject: UNII:5TAA004E22

object_name: Grade III Childhood Astrocytoma


subject: UNII:5TAA004E22

object_name: Adult Anaplastic Astrocytoma


subject: UNII:5TAA004E22

object_name: anaplastic astrocytoma


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:16664

subject_name: Albendazole

object_name: Kala-Azar


subject: CHEBI:18248

subject_name: Iron


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:16302


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: CHEBI:6504

object_name: pediatric osteosarcoma


subject: CHEBI:6504

object_name: Osteosarcoma


subject: UMLS:C2699548

object_name: Solid Neoplasm


subject: CHEBI:47426

subject_name: Furosemide

object_name: Abnormal renal physiology


subject: CHEBI:74073

subject_name: Ile-Met

object_name: AIDS


subject: CHEBI:30366

subject_name: imidazolide


subject: CHEBI:231678

subject_name: Evofosfamide

object_name: Childhood Solid Neoplasm


subject: CHEBI:231678

object_name: Adult Solid Neoplasm


subject: CHEBI:40279

subject_name: Allopurinol

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEBI:40279

object_name: Neonatal disorder


subject: UMLS:C3541932

subject_name: Moringa oleifera extract

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C3541932

object_name: metabolic syndrome X


subject: UMLS:C3541932

object_name: Nutritional and Metabolic Diseases


subject: CHEBI:71157

subject_name: Dobesilic acid

object_name: diabetic retinopathy


subject: UMLS:C0877940

subject_name: Doxium


subject: CHEBI:187893

subject_name: Baclofen

object_name: fragile X syndrome


subject: CHEMBL.COMPOUND:CHEMBL461806

subject_name: ELTROMBOPAG OLAMINE

object_name: Myelodysplasia


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: childhood myelodysplastic syndrome


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C1880492

subject_name: eltrombopag olamine


subject: UMLS:C1880492


subject: UMLS:C1880492


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: fallopian tube carcinoma


subject: UNII:M89N0Q7EQR

object_name: fallopian tube cancer


subject: UNII:M89N0Q7EQR

object_name: peritoneum cancer


subject: CHEBI:40279

object_name: ovarian cancer


subject: CHEBI:40279

object_name: ovarian neoplasm


subject: CHEBI:40279

object_name: ovarian carcinoma


subject: CHEBI:40279


subject: CHEBI:40279


subject: CHEBI:40279


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: UNII:51M3FB9B9E

object_name: kidney failure


subject: MESH:D000084922

subject_name: Resistant Starch

object_name: Parkinson disease


subject: UNII:Z541VW0W40

object_name: neoplasm


subject: UNII:Z541VW0W40

object_name: Tumor Mass


subject: DRUGBANK:DB18453

object_name: Safety Issues


subject: PUBCHEM.COMPOUND:9794806

subject_name: HUPERZINE A

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:9794806

object_name: Presenile dementia


subject: PUBCHEM.COMPOUND:9794806

object_name: dementia


subject: CHEBI:178022

subject_name: huperzine A(1+)


subject: CHEBI:178022


subject: CHEBI:178022


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: Malignant neoplasm of female breast


subject: CHEBI:27013

subject_name: Tocopherol


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:15367

subject_name: Tretinoin


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: CHEBI:50692

subject_name: Mifepristone


subject: PUBCHEM.COMPOUND:16129679

subject_name: VIP

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:80331

subject_name: Vasoactive intestinal peptide


subject: PUBCHEM.COMPOUND:70691420

subject_name: Aviptadil


subject: CHEBI:167574

subject_name: Semaglutide

object_name: type 1 diabetes mellitus 1


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: metastatic colorectal cancer


subject: CHEBI:135915

object_name: colorectal cancer


subject: CHEBI:135915

object_name: colorectal carcinoma


subject: CHEBI:135915

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:74328238

subject_name: Sotagliflozin

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:74328238

object_name: diabetic kidney disease


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Invasive Bladder Giant Cell Urothelial Carcinoma


subject: CHEBI:31355

object_name: Invasive Bladder Urothelial Carcinoma with Trophoblastic Differentiation


subject: CHEBI:31355

object_name: infiltrating bladder urothelial carcinoma, clear cell variant


subject: CHEBI:31355

object_name: Invasive Bladder Urothelial Carcinoma with Glandular Differentiation


subject: CHEBI:31355

object_name: nested variant infiltrating bladder urothelial carcinoma


subject: CHEBI:31355

object_name: infiltrating bladder urothelial carcinoma sarcomatoid variant


subject: CHEBI:31355

object_name: plasmacytoid variant infiltrating bladder urothelial carcinoma


subject: CHEBI:31355

object_name: bladder adenocarcinoma


subject: CHEBI:31355

object_name: micropapillary variant infiltrating bladder urothelial carcinoma


subject: CHEBI:31355

object_name: bladder transitional cell carcinoma


subject: CHEBI:31355

object_name: bladder mixed adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816

object_name: transitional cell carcinoma


subject: CHEBI:64816

object_name: bladder squamous cell carcinoma


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: UMLS:C3179325

subject_name: PRO 140

object_name: HIV-1 infection


subject: PUBCHEM.COMPOUND:11236066

subject_name: BRIMONIDINE TARTRATE

object_name: ocular hypertension


subject: PUBCHEM.COMPOUND:11236066

object_name: Ocular hypertension


subject: PUBCHEM.COMPOUND:11236066

object_name: glaucoma


subject: PUBCHEM.COMPOUND:11236066

object_name: Glaucoma, CTCAE


subject: CHEBI:31587

subject_name: Exatecan mesilate hydrate

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: CHEBI:31587

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: CHEBI:31587

object_name: gallbladder cancer


subject: CHEBI:31587

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: CHEBI:31587

object_name: Stage III Gallbladder Cancer AJCC v8


subject: CHEBI:31587

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: CHEBI:31587

object_name: gallbladder carcinoma


subject: CHEBI:31587

object_name: extrahepatic bile duct carcinoma


subject: CHEBI:31587

object_name: malignant tumor of extrahepatic bile duct


subject: CHEBI:135709

subject_name: Exatecan


subject: CHEBI:135709


subject: CHEBI:135709


subject: CHEBI:135709


subject: CHEBI:135709


subject: CHEBI:135709


subject: CHEBI:135709


subject: CHEBI:135709


subject: CHEBI:135709


subject: UMLS:C0935945

subject_name: exatecan mesylate


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UMLS:C0935945


subject: UNII:37KZM6S21G

subject_name: cerebrolysin

object_name: vascular dementia


subject: UMLS:C0055108


subject: CHEBI:188219

object_name: Alzheimer disease type 1


subject: CHEBI:188219

object_name: Alzheimer disease


subject: UMLS:C5814503

object_name: Pompe's disease adult onset


subject: UMLS:C5814503

object_name: glycogen storage disease due to acid maltase deficiency, late-onset


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: acute coronary syndrome


subject: CHEBI:231324

subject_name: alpelisib

object_name: uveal melanoma


subject: UMLS:C2986399


subject: UMLS:C1739076

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C1739076

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: substance withdrawal syndrome


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: non-small cell lung carcinoma


subject: CHEBI:81579

object_name: lung cancer


subject: CHEBI:81579

object_name: lung carcinoma


subject: UMLS:C5240561

subject_name: Vaccine product containing only Human alphaherpesvirus 3 antigen (medicinal product)

object_name: psoriasis


subject: CHEBI:58097

object_name: adverse effect


subject: CHEBI:58097

object_name: Pain Relief


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:27732

subject_name: Caffeine

object_name: Hypoxemia


subject: CHEBI:27732

object_name: Hypoxia, CTCAE


subject: UMLS:C2919980

subject_name: passiflora incarnata flowering top extract

object_name: Blood Pressure Finding


subject: UMLS:C2919980

object_name: Systemic arterial pressure


subject: UMLS:C2919980

object_name: Tachycardia


subject: UMLS:C4059137

subject_name: Passiflora incarnata whole extract


subject: UMLS:C4059137


subject: UMLS:C4059137


subject: UMLS:C3495130

subject_name: Passiflora incarnata homeopathic preparation


subject: UMLS:C3495130


subject: UMLS:C3495130


subject: UMLS:C0962969

subject_name: RAD 001

object_name: gastric neoplasm


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: CHEBI:42944

subject_name: Galantamine

object_name: autism


subject: CHEBI:42944

object_name: pervasive developmental disorder


subject: UMLS:C5557556

subject_name: AHCC

object_name: ovarian carcinoma


subject: UMLS:C5557556

object_name: fallopian tube carcinoma


subject: UMLS:C5557556

object_name: Carcinoma of peritoneum


subject: UMLS:C5557556

object_name: peritoneal carcinoma


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: generalized anxiety disorder


subject: CHEBI:31236

object_name: panic disorder


subject: CHEBI:31236

object_name: panic disorder 1


subject: CHEBI:44915

subject_name: Propofol

object_name: Upper Respiratory Infections


subject: CHEBI:44915

object_name: respiratory tract infectious disorder


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802


subject: UNII:53O87HA2QU

subject_name: Defactinib

object_name: Myelodysplasia


subject: UNII:53O87HA2QU

object_name: juvenile myelomonocytic leukemia


subject: UNII:53O87HA2QU

object_name: chronic myelomonocytic leukemia


subject: UNII:53O87HA2QU

object_name: acute myeloid leukemia by FAB classification


subject: UNII:53O87HA2QU

object_name: acute myeloid leukemia


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)

object_name: hypogonadotropic hypogonadism 7 with or without anosmia


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: PUBCHEM.COMPOUND:21888462

subject_name: Menotrophin


subject: UMLS:C0025326

subject_name: Menotropins


subject: UMLS:C5575602

subject_name: Cell Culture Serum

object_name: non-small cell lung carcinoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Autoimmunity


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: Inguinal hernia


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: small cell carcinoma


subject: CHEBI:231342

subject_name: ceralasertib

object_name: triple-negative breast carcinoma


subject: CHEBI:63626

subject_name: Tesamorelin

object_name: chronic obstructive pulmonary disease


subject: UMLS:C1313807


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2

object_name: metabolic bone disorder


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: PUBCHEM.COMPOUND:5280374


subject: CHEBI:28869

subject_name: Menadione


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: CHEBI:16374

subject_name: Menatetrenone


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: intestinal disorder


subject: CHEBI:43034


subject: CHEBI:42485

subject_name: formyl group


subject: CHEBI:74498

subject_name: 5-fluoroorotic acid


subject: MESH:D013024

subject_name: Soybean Oil


subject: CHEBI:166975

subject_name: soybean oil


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: CHEBI:45822

subject_name: sulfur monoxide


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Marginal zone lymphoma stage II


subject: CHEBI:91397

object_name: Follicular lymphoma stage II


subject: CHEBI:91397

object_name: Follicle centre lymphoma, follicular grade I, II, III stage IV


subject: CHEBI:91397

object_name: Marginal zone lymphoma stage III


subject: CHEBI:91397

object_name: Follicular lymphoma stage III


subject: CHEBI:91397

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:91397

object_name: CD20 Positive


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:3699

subject_name: Cimetidine

object_name: HIV infection


subject: PUBCHEM.COMPOUND:20642899

subject_name: ZOLUNICANT

object_name: Chiclero ulcer


subject: PUBCHEM.COMPOUND:20642899

object_name: Adverse drug response


subject: UNII:KX8NQX91Z8


subject: UNII:KX8NQX91Z8


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: inborn mitochondrial metabolism disorder


subject: CHEBI:46245

object_name: mitochondrial disease


subject: UNII:3A3U0GI71G

subject_name: Magnesium oxide

object_name: type 2 diabetes mellitus


subject: UNII:3A3U0GI71G

object_name: Diabetes


subject: UNII:3A3U0GI71G

object_name: diabetes mellitus


subject: CHEBI:31794

subject_name: magnesium oxide


subject: CHEBI:31794


subject: CHEBI:31794


subject: CHEBI:82960

subject_name: Raltegravir

object_name: chronic hepatitis C virus infection


subject: UMLS:C4722571

object_name: secondary hyperparathyroidism


subject: UMLS:C4722571

object_name: vitamin D deficiency


subject: CHEBI:7496

subject_name: Nelfinavir

object_name: Plasma cell myeloma refractory


subject: CHEBI:7496

object_name: Plasma cell myeloma recurrent


subject: CHEBI:31905

subject_name: Nicorandil

object_name: end stage renal failure


subject: CHEBI:31905

object_name: Chronic uremia


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: epithelioid sarcoma


subject: CHEBI:231598

object_name: adult epithelioid sarcoma


subject: CHEBI:231598

object_name: childhood epithelioid sarcoma


subject: UNII:7V7IHI0SYG

object_name: adult acute myeloid leukemia


subject: CHEBI:229212

subject_name: Pirtobrutinib

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:229212

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:229212

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:06IVK87M04

subject_name: Zelavespib

object_name: Solid Neoplasm


subject: UNII:06IVK87M04

object_name: adult lymphoma


subject: UNII:06IVK87M04

object_name: lymphoma


subject: UNII:06IVK87M04

object_name: pediatric lymphoma


subject: UMLS:C4310558


subject: UMLS:C4310558


subject: UMLS:C4310558


subject: UMLS:C4310558


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: Light for dates


subject: UNII:OUJ6OQ79EF

subject_name: PROLYL ENDOPEPTIDASE

object_name: celiac disease


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: hepatitis C


subject: CHEBI:135915

object_name: chronic hepatitis C virus infection


subject: UNII:R3T98GBE3C

object_name: pulmonary tuberculosis


subject: UNII:R3T98GBE3C

object_name: tuberculosis


subject: CHEBI:166520

subject_name: Tenamfetamine

object_name: drug dependence


subject: CHEBI:1391

subject_name: Midomafetamine


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: shoulder pain chronic


subject: CHEBI:3215

object_name: chronic shoulder pain


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:60802


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Prediabetes


subject: UMLS:C2348288

object_name: Nutritional status


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: UMLS:C2348261

subject_name: Dietary Chromium


subject: CHEBI:28073

subject_name: Chromium


subject: CHEBI:49544

subject_name: Chromic cation


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UMLS:C1874237

subject_name: ANALGESICS,TOPICAL

object_name: neuralgia


subject: UMLS:C1874237

object_name: Neuropathic pain


subject: CHEBI:22198

subject_name: acetylcysteine

object_name: autoimmune thrombocytopenia


subject: CHEBI:22198

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:22198

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939


subject: CHEBI:28939


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:17561


subject: CHEBI:17561


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:39548


subject: UNII:6A1X56B95E

subject_name: Rapastinel

object_name: Compulsion


subject: UMLS:C1666271

subject_name: GLYX-13 peptide


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: bacteriemia


subject: CHEBI:63611

object_name: Bacteremia, CTCAE


subject: CHEBI:63611

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:63611

object_name: non-Hodgkin lymphoma


subject: CHEBI:63611

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:63611

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:63611

object_name: Hodgkin Disease


subject: CHEBI:63611

object_name: plasma cell myeloma


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Vascular Stiffness


subject: UNII:MH5DMF9JKY

subject_name: Emavusertib

object_name: Refractory Central Nervous System Lymphoma


subject: UNII:MH5DMF9JKY

object_name: refractory hematologic cancer


subject: UNII:MH5DMF9JKY

object_name: Recurrent Hematologic Malignancy


subject: PUBCHEM.COMPOUND:118224238


subject: PUBCHEM.COMPOUND:118224238


subject: PUBCHEM.COMPOUND:118224238


subject: CHEBI:91397

subject_name: Ibrutinib


subject: CHEBI:91397


subject: CHEBI:63918

subject_name: Artesunate

object_name: Malaria suspected


subject: CHEBI:16436

subject_name: Citicoline

object_name: Acute Ischemic Stroke


subject: UNII:MO0N1J0SEN

subject_name: Azoxymethane

object_name: bipolar I disorder


subject: UNII:MO0N1J0SEN

object_name: schizophrenia


subject: UNII:MO0N1J0SEN

object_name: schizoaffective disorder


subject: CHEBI:600103

subject_name: daptomycin

object_name: Drug Interactions


subject: UMLS:C5854652

subject_name: RNA-lipoplex Cancer Vaccine BNT116

object_name: non-small cell lung carcinoma


subject: UMLS:C0078058

subject_name: endothelial growth factor A, vascular


subject: PR:000017284

subject_name: vascular endothelial growth factor A, long form


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Alcohol Withdrawal Seizures


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:90936

subject_name: Alectinib

object_name: Mutation Abnormality


subject: UNII:U2I8T43Y7R

subject_name: axicabtagene ciloleucel

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:U2I8T43Y7R

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:U2I8T43Y7R

object_name: grade 3B follicular lymphoma


subject: DRUGBANK:DB16582

subject_name: Lisocabtagene maraleucel


subject: DRUGBANK:DB16582


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab


subject: UNII:LDJ89SS0YG

object_name: primary mediastinal large B-cell lymphoma


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: UNII:Q6C9WHR03O

subject_name: tisagenlecleucel


subject: UNII:Q6C9WHR03O


subject: UMLS:C4733318

object_name: endogenous depression


subject: UMLS:C4733318

object_name: major depressive disorder


subject: UMLS:C4049933

subject_name: Anesthesia substance

object_name: bladder tumor


subject: UMLS:C4049933

object_name: urinary bladder carcinoma


subject: UMLS:C4049933

object_name: urinary bladder cancer


subject: UMLS:C4049933

object_name: childhood bladder carcinoma


subject: UNII:C857R7G2U6

subject_name: SODIUM PENTABORATE PENTAHYDRATE

object_name: postmenopausal osteoporosis


subject: UNII:C857R7G2U6

object_name: osteoporosis


subject: UMLS:C5848978

subject_name: Sodium Pentaborate Pentahydrate


subject: UMLS:C5848978


subject: PUBCHEM.COMPOUND:242911

object_name: Common Migraine


subject: UMLS:C4305840


subject: UMLS:C5853504

object_name: wet macular degeneration


subject: CHEBI:33569

subject_name: noradrenaline

object_name: postperfusion syndrome


subject: CHEBI:166902


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:194548

subject_name: Racepinephrine


subject: MESH:C000721530

subject_name: andrographolide sulfonate

object_name: bronchitis


subject: MESH:C000721530

object_name: Acute bronchitis


subject: CHEBI:404903

subject_name: Ertapenem

object_name: Klebsiella pneumoniae infection


subject: CHEBI:404903

object_name: Enterobacteriaceae Infections


subject: CHEBI:404903

object_name: escherichia coli infection


subject: CHEBI:404903

object_name: Drug Resistance, Bacterial


subject: CHEBI:6770

subject_name: MEROPENEM


subject: CHEBI:6770


subject: CHEBI:6770


subject: CHEBI:6770


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN

object_name: urinary tract infection


subject: UNII:X00B0D5O0E

object_name: Recurrent urinary tract infections


subject: UNII:X00B0D5O0E


subject: UNII:X00B0D5O0E


subject: UNII:X00B0D5O0E


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:8232


subject: CHEBI:8232


subject: CHEBI:8232


subject: CHEBI:8232


subject: UNII:L7451S9126

subject_name: Crizanlizumab

object_name: retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations


subject: CHEBI:8774

subject_name: Ramipril

object_name: heart failure


subject: CHEBI:8774

object_name: Heart Failure, CTCAE


subject: UMLS:C5439503

subject_name: Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens only vaccine product

object_name: lung cancer


subject: UMLS:C5439503

object_name: lung neoplasm


subject: UMLS:C5439503

object_name: lung carcinoma


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: Childhood Breast Carcinoma


subject: CHEBI:50749

object_name: breast carcinoma


subject: CHEBI:50749

object_name: breast cancer


subject: CHEBI:145431

subject_name: Indisulam

object_name: Carcinoma breast stage IV


subject: UMLS:C0879271


subject: UMLS:C1831847

subject_name: Live Freeze-Dried Lactic Acid Bacteria Probiotic

object_name: Gastrointestinal complication


subject: UMLS:C1831847

object_name: constipation, impaction, and bowel obstruction


subject: UMLS:C1831847

object_name: cognitive/functional effects


subject: UMLS:C1831847

object_name: psychosocial effects of cancer and its treatment


subject: UMLS:C1831847

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C1831847

object_name: diarrhea


subject: UMLS:C1831847

object_name: rectal discharge diarrhea (physical finding)


subject: UMLS:C1831847

object_name: Diarrhea, CTCAE


subject: UMLS:C1831847

object_name: Fatigue, CTCAE 5.0


subject: UMLS:C1831847

object_name: Fatigue


subject: CHEBI:310388

subject_name: ciprofloxacin hydrochloride (anhydrous)

object_name: otitis externa


subject: CHEBI:310388

object_name: Otitis Externa, CTCAE


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: UMLS:C5203431

subject_name: Gemcitabine Liquid Injection

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Crohn disease


subject: PUBCHEM.COMPOUND:73151030

object_name: inflammatory bowel disease


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: viral disease


subject: PUBCHEM.COMPOUND:54680690

subject_name: demeclocycline

object_name: brain neoplasm


subject: CHEBI:4392

subject_name: Demeclocycline


subject: CHEBI:36080

subject_name: protein

object_name: bariatric surgery candidate


subject: UMLS:C0033684

subject_name: Proteins


subject: PR:000000001


subject: CHEBI:10100

subject_name: Zafirlukast

object_name: ovarian cancer


subject: CHEBI:10100

object_name: ovarian neoplasm


subject: CHEBI:10100

object_name: ovarian carcinoma


subject: CHEBI:91414

subject_name: Adavosertib

object_name: Advanced Gastric Adenocarcinoma


subject: UMLS:C4053677


subject: CHEBI:24261

subject_name: glucocorticoid

object_name: prostate neoplasm


subject: UMLS:C5206273

subject_name: Anti-CD137 Agonistic Monoclonal Antibody CTX-471

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5206273

object_name: Embolism, Tumor


subject: UMLS:C5206273

object_name: Neoplasm Metastasis


subject: UMLS:C5206273

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C5206273

object_name: Neck Carcinoma


subject: UMLS:C5206273

object_name: head and neck neoplasm


subject: UMLS:C5206273

object_name: head and neck cancer


subject: UMLS:C5206273

object_name: non-small cell lung carcinoma


subject: UMLS:C5206273

object_name: small cell lung carcinoma


subject: UMLS:C5206273

object_name: Mesothelioma


subject: UMLS:C5206273

object_name: mesothelial neoplasm


subject: UMLS:C5206273

object_name: malignant mesothelioma


subject: UMLS:C5206273

object_name: melanoma


subject: CHEBI:184662

object_name: colorectal cancer


subject: CHEBI:184662

object_name: colorectal carcinoma


subject: CHEBI:184662

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:184662

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:184662


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEMBL.COMPOUND:CHEMBL256907


subject: CHEMBL.COMPOUND:CHEMBL256907


subject: CHEMBL.COMPOUND:CHEMBL256907


subject: CHEMBL.COMPOUND:CHEMBL256907


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:63608


subject: CHEBI:63608


subject: CHEBI:63608


subject: CHEBI:63608


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: Carbon Monoxide Poisoning


subject: PUBCHEM.COMPOUND:24492

subject_name: Boric acid (HBO2)


subject: UMLS:C0030069

subject_name: Oxyhemoglobin


subject: UMLS:C3896909

object_name: Carcinoma breast stage IV


subject: UMLS:C3896909

object_name: triple-negative breast carcinoma


subject: UMLS:C3896909

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C3896909

object_name: Hormone receptor positive tumor


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: myocarditis


subject: UNII:C8ADC441ME

object_name: viral myocarditis


subject: UNII:C8ADC441ME

object_name: Myocarditis, CTCAE 5.0


subject: UNII:C8ADC441ME

object_name: Myocarditis, CTCAE 3.0


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Primary malignant neoplasm


subject: PUBCHEM.COMPOUND:5281767

object_name: cancer


subject: PUBCHEM.COMPOUND:5281767

object_name: childhood malignant neoplasm


subject: PUBCHEM.COMPOUND:5281767

object_name: Malignant obstetric neoplasm


subject: PUBCHEM.COMPOUND:5281767

object_name: Bladder Spasm, CTCAE 5.0


subject: PUBCHEM.COMPOUND:5281767

object_name: Bladder Spasm


subject: PUBCHEM.COMPOUND:5281767

object_name: Urinary Urgency


subject: PUBCHEM.COMPOUND:5281767

object_name: Urinary Urgency, CTCAE


subject: CHEBI:4798

subject_name: Entacapone

object_name: Plexosarcoma


subject: UNII:HV6MT68KKF

subject_name: SEVIRUMAB

object_name: cytomegalovirus retinitis


subject: UNII:HV6MT68KKF

object_name: HIV infection


subject: UMLS:C0914798

subject_name: sevirumab


subject: UMLS:C0914798


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: inherited hemoglobinopathy


subject: UNII:Q46947FE7K

object_name: hemoglobinopathy


subject: CHEBI:94463


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: Graves disease


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0795649

subject_name: oat bran

object_name: spinal cord injury


subject: UNII:3XPI7EG4W8

subject_name: patritumab deruxtecan

object_name: Metastatic non-small cell lung cancer


subject: UNII:3XPI7EG4W8

object_name: Non-small cell lung cancer with mutation in epidermal growth factor receptor


subject: UMLS:C4527158


subject: UMLS:C4527158


subject: UMLS:C2703096

object_name: human papilloma virus infection


subject: CHEBI:4672

subject_name: Docetaxel

object_name: drug-induced liver injury


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:83766

subject_name: Olaparib

object_name: Small cell lung cancer extensive stage


subject: UMLS:C5400018

subject_name: Defibrotide, Pig

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5400018

object_name: neurotoxicity


subject: UNII:438HCF2X0M

subject_name: Defibrotide


subject: UNII:438HCF2X0M


subject: UNII:53O87HA2QU

subject_name: Defactinib

object_name: Solid Neoplasm


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: Pregnant


subject: UMLS:C5433690

subject_name: RC28-E protein

object_name: diabetic macular edema


subject: CHEBI:114785

subject_name: Erlotinib

object_name: advanced hepatic fibrosis


subject: CHEBI:114785

object_name: liver cirrhosis


subject: UNII:6QTJ9P2NYT

object_name: type 2 diabetes mellitus


subject: UNII:6QTJ9P2NYT

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UNII:6QTJ9P2NYT

object_name: Obesity, CTCAE


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: pneumonia


subject: CHEBI:32016

object_name: COVID-19-Associated Pneumonia


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: High-Risk Cancer


subject: UMLS:C1948073


subject: UMLS:C0036557

subject_name: Sedatives

object_name: acute bronchiolitis


subject: UMLS:C0036557


subject: UMLS:C0036557


subject: CHEBI:142432

subject_name: Vericiguat

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:142432

object_name: pulmonary hypertension


subject: CHEBI:142432

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:142432

object_name: pulmonary arterial hypertension


subject: CHEBI:32127

subject_name: sevelamer

object_name: hypertension


subject: CHEBI:32127

object_name: Hypertension, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5314349

subject_name: SEVELAMER


subject: CHEMBL.COMPOUND:CHEMBL5314349


subject: UNII:9YCX42I8IU

subject_name: sevelamer carbonate


subject: UNII:9YCX42I8IU


subject: CHEBI:32139


subject: CHEBI:32139


subject: CHEBI:34683


subject: CHEBI:34683


subject: CHEBI:37583

subject_name: trisodium phosphate


subject: CHEBI:37583


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: ovarian cancer


subject: UMLS:C2830069

object_name: ovarian neoplasm


subject: UMLS:C2830069

object_name: ovarian carcinoma


subject: UMLS:C2830069

object_name: Childhood Solid Neoplasm


subject: UMLS:C2830069

object_name: Adult Solid Neoplasm


subject: UMLS:C2830069

object_name: Solid Neoplasm


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863


subject: UNII:D45TI2TWMA

object_name: Acute Stroke


subject: DRUGBANK:DB12595

subject_name: Nerinetide


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Malignant melanoma of skin of breast


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:47898

subject_name: Epirubicin


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: Left atrial fibrosis


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Endometrial bleeding


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: UNII:7K28NB895L

subject_name: Belzutifan

object_name: Moderate Hepatic Insufficiency


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Metastatic Colorectal Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: bile duct carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: bile duct cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage II Colon Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: Stage II Colon Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage II Colon Cancer


subject: UNII:2S9ZZM9Q9V

object_name: Advanced Colorectal Carcinoma


subject: CHEBI:70839

subject_name: Dasatinib

object_name: esophageal cancer


subject: CHEBI:70839

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:70839

object_name: neoplasm of esophagus


subject: CHEBI:70839

object_name: gastric cancer


subject: CHEBI:70839

object_name: Stage II Rectal Cancer AJCC v7


subject: CHEBI:70839

object_name: Stage II Rectal Cancer AJCC v8


subject: CHEBI:70839

object_name: Stage II Rectal Cancer


subject: CHEBI:70839

object_name: Stage III Rectal Cancer AJCC v6


subject: CHEBI:70839

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:70839

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:70839

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:70839

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:70839

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:70839

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:70839

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:70839

object_name: bile duct carcinoma


subject: CHEBI:70839

object_name: bile duct cancer


subject: CHEBI:70839

object_name: Stage II Colon Cancer AJCC v8


subject: CHEBI:70839

object_name: Stage II Colon Cancer AJCC v7


subject: CHEBI:70839

object_name: Stage II Colon Cancer


subject: CHEBI:70839

object_name: gallbladder cancer


subject: CHEBI:70839

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:70839

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:70839

object_name: Stage III Colon Cancer


subject: CHEBI:70839

object_name: Advanced Colorectal Carcinoma


subject: CHEBI:70839

object_name: small intestine adenocarcinoma


subject: CHEBI:190514

object_name: esophageal cancer


subject: CHEBI:190514

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:190514

object_name: neoplasm of esophagus


subject: CHEBI:190514

object_name: gastric cancer


subject: CHEBI:190514

object_name: Stage II Rectal Cancer AJCC v7


subject: CHEBI:190514

object_name: Stage II Rectal Cancer AJCC v8


subject: CHEBI:190514

object_name: Stage II Rectal Cancer


subject: CHEBI:190514

object_name: Stage III Rectal Cancer AJCC v6


subject: CHEBI:190514

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:190514

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:190514

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:190514

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:190514

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:190514

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:190514

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:190514

object_name: bile duct carcinoma


subject: CHEBI:190514

object_name: bile duct cancer


subject: CHEBI:190514

object_name: Stage II Colon Cancer AJCC v8


subject: CHEBI:190514

object_name: Stage II Colon Cancer AJCC v7


subject: CHEBI:190514

object_name: Stage II Colon Cancer


subject: CHEBI:190514

object_name: gallbladder cancer


subject: CHEBI:190514

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:190514

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:190514

object_name: Stage III Colon Cancer


subject: CHEBI:190514

object_name: Advanced Colorectal Carcinoma


subject: CHEBI:190514

object_name: small intestine adenocarcinoma


subject: CHEBI:49375

object_name: esophageal cancer


subject: CHEBI:49375

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:49375

object_name: neoplasm of esophagus


subject: CHEBI:49375

object_name: gastric cancer


subject: CHEBI:49375

object_name: Stage II Rectal Cancer AJCC v7


subject: CHEBI:49375

object_name: Stage II Rectal Cancer AJCC v8


subject: CHEBI:49375

object_name: Stage II Rectal Cancer


subject: CHEBI:49375

object_name: Stage III Rectal Cancer AJCC v6


subject: CHEBI:49375

object_name: Stage III Rectal Cancer AJCC v7


subject: CHEBI:49375

object_name: Stage III Rectal Cancer AJCC v8


subject: CHEBI:49375

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:49375

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:49375

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:49375

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:49375

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:49375

object_name: bile duct carcinoma


subject: CHEBI:49375

object_name: bile duct cancer


subject: CHEBI:49375

object_name: Stage II Colon Cancer AJCC v8


subject: CHEBI:49375

object_name: Stage II Colon Cancer AJCC v7


subject: CHEBI:49375

object_name: Stage II Colon Cancer


subject: CHEBI:49375

object_name: gallbladder cancer


subject: CHEBI:49375

object_name: Stage III Colon Cancer AJCC v7


subject: CHEBI:49375

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:49375

object_name: Stage III Colon Cancer


subject: CHEBI:49375

object_name: Advanced Colorectal Carcinoma


subject: CHEBI:49375

object_name: small intestine adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:133021

subject_name: Venetoclax

object_name: acute leukemia


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: Severely increased total eosinophil count


subject: CHEBI:145371

subject_name: Binimetinib

object_name: thyroid tumor


subject: CHEBI:145371

object_name: thyroid cancer


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: glioma


subject: UMLS:C0879636

subject_name: IMC C225


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381

object_name: malignant glioma


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:191174


subject: CHEBI:191174

object_name: thyroid gland carcinoma


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: PUBCHEM.COMPOUND:43805

object_name: melanoma


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C5959674

subject_name: IDO1 Inhibitor RiMO-401

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109482

object_name: smoldering plasma cell myeloma


subject: UMLS:C2981844

subject_name: Bersanlimab


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: adverse effect


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Anterior Cruciate Ligament Tear


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Lymphocytosis


subject: CHEBI:63791

object_name: Lymphadenopathy


subject: CHEBI:63791

object_name: agammaglobulinemia


subject: CHEBI:63791

object_name: syndromic agammaglobulinemia


subject: CHEBI:63791

object_name: thrombocytopenia


subject: CHEBI:63791

object_name: Night sweats


subject: CHEBI:63791

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:63791

object_name: Fatigue


subject: CHEBI:63791

object_name: Fever


subject: CHEBI:63791

object_name: Fever symptoms (finding)


subject: CHEBI:63791

object_name: Fever, CTCAE


subject: CHEBI:28887

subject_name: Ofatumumab


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887

object_name: Paraproteinemia


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: CHEBI:28887


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: CHEBI:4875

subject_name: Etanercept

object_name: Cachexia


subject: CHEBI:4875

object_name: Anorexia


subject: CHEBI:4875

object_name: Anorexia, CTCAE


subject: CHEBI:4875

object_name: Anorexia symptom


subject: CHEBI:4875

object_name: unspecified adult solid tumor, protocol specific


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: PR:000001959


subject: PR:000001959


subject: PR:000001959


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]

object_name: Chronic low back pain


subject: UNII:832O37V7MZ

subject_name: Nacubactam

object_name: gram-negative bacterial infections


subject: UMLS:C5139691

subject_name: nacubactam


subject: CHEBI:135810

subject_name: Atrasentan

object_name: renal carcinoma


subject: CHEBI:135810

object_name: kidney neoplasm


subject: CHEBI:135810

object_name: kidney cancer


subject: UMLS:C1765313

subject_name: Atrasentan Hydrochloride


subject: UMLS:C1765313


subject: UMLS:C1765313


subject: UNII:S98NFM1378

object_name: acute myeloid leukemia by FAB classification


subject: UNII:S98NFM1378

object_name: acute myeloid leukemia


subject: CHEBI:94386

subject_name: Mibefradil

object_name: glioblastoma


subject: CHEBI:135983

subject_name: Teriparatide

object_name: rheumatoid arthritis


subject: UMLS:C1366031

subject_name: Rhubarb Root

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1366031

object_name: obesity


subject: UMLS:C1366031

object_name: Obesity, CTCAE


subject: CHEBI:9112

subject_name: sennoside A


subject: CHEBI:9112


subject: CHEBI:9112


subject: DRUGBANK:DB15889

subject_name: Senna leaf


subject: DRUGBANK:DB15889


subject: DRUGBANK:DB15889


subject: CHEMBL.COMPOUND:CHEMBL2108558

subject_name: SENNA


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: UNII:3FYP5M0IJX

subject_name: Sennosides


subject: UNII:3FYP5M0IJX


subject: UNII:3FYP5M0IJX


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: Thymidine kinase 2 deficiency


subject: CHEBI:15698

object_name: mitochondrial DNA depletion syndrome, myopathic form


subject: CHEBI:17748

subject_name: Thymidine


subject: CHEBI:17748


subject: CHEBI:169833

subject_name: Deacetyldiltiazem

object_name: Permanent atrial fibrillation


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:6904

subject_name: Metoprolol


subject: UMLS:C1512511

subject_name: Human Papilloma Virus Vaccine

object_name: recurrent respiratory papillomatosis


subject: UMLS:C5395272

subject_name: Vaccine product containing only Human papillomavirus antigen (medicinal product)


subject: UMLS:C1699394

subject_name: Hylenex

object_name: urothelial carcinoma


subject: UMLS:C1699394

object_name: transitional cell carcinoma


subject: CHEBI:135905

subject_name: Terlipressin

object_name: kidney failure


subject: PUBCHEM.COMPOUND:52415

subject_name: dicarboxydine

object_name: plasma cell myeloma


subject: CHEBI:147423

subject_name: cyanoguanidine


subject: CHEBI:58593


subject: CHEBI:28846

subject_name: dCDP


subject: UMLS:C0038889

subject_name: Endogenous Surfactants

object_name: Neonatal death


subject: CHEBI:35195

subject_name: surfactant


subject: UMLS:C2825078

subject_name: Surfactant [EPC]


subject: PUBCHEM.COMPOUND:139300919

subject_name: CRISUGABALIN

object_name: neuralgia


subject: PUBCHEM.COMPOUND:139300919

object_name: Neuropathic pain


subject: DRUGBANK:DB19300

subject_name: Crisugabalin


subject: DRUGBANK:DB19300


subject: CHEBI:94534

subject_name: olanzapine

object_name: pervasive developmental disorder


subject: CHEBI:94534

object_name: autism


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: periodontitis, chronic, adult


subject: CHEBI:25681

object_name: chronic periodontitis


subject: CHEBI:93775

subject_name: Amethopterin

object_name: High Grade Osteosarcoma


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:31859

subject_name: Modafinil

object_name: Dependence


subject: UMLS:C0935874

object_name: lung neoplasm


subject: UMLS:C2720164

object_name: metastatic melanoma


subject: CHEBI:93776

subject_name: Pevonedistat


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Application site discomfort


subject: CHEBI:3215

object_name: Medical device discomfort


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918


subject: UMLS:C5783512

subject_name: BET/CBP/p300 Inhibitor EP31670

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C5783512

object_name: chronic myelomonocytic leukemia


subject: UMLS:C5783512

object_name: NUT Carcinoma


subject: UMLS:C5783512

object_name: myelofibrosis


subject: UMLS:C0879272

object_name: plasma cell myeloma


subject: UMLS:C5565182


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: dyskeratosis congenita


subject: UNII:6ZA31Y954Z

subject_name: Brodalumab

object_name: lung cancer


subject: UNII:6ZA31Y954Z


subject: UNII:6ZA31Y954Z

object_name: lung carcinoma


subject: UNII:6ZA31Y954Z

object_name: lip and oral cavity carcinoma


subject: UNII:6ZA31Y954Z

object_name: oral cavity cancer


subject: UNII:6ZA31Y954Z

object_name: skin neoplasm


subject: UNII:6ZA31Y954Z

object_name: skin cancer


subject: UNII:6ZA31Y954Z

object_name: liver cancer


subject: UNII:6ZA31Y954Z

object_name: liver neoplasm


subject: UNII:6ZA31Y954Z

object_name: Adult Liver Carcinoma


subject: UNII:6ZA31Y954Z

object_name: liver carcinoma


subject: UNII:6ZA31Y954Z

object_name: colon carcinoma


subject: UNII:6ZA31Y954Z

object_name: colorectal cancer


subject: UNII:6ZA31Y954Z

object_name: colon cancer


subject: UNII:6ZA31Y954Z

object_name: prostate carcinoma


subject: UNII:6ZA31Y954Z

object_name: prostate cancer


subject: UNII:6ZA31Y954Z

object_name: Childhood Breast Carcinoma


subject: UNII:6ZA31Y954Z

object_name: breast carcinoma


subject: UNII:6ZA31Y954Z

object_name: breast cancer


subject: UNII:6ZA31Y954Z

object_name: rectal carcinoma


subject: UNII:6ZA31Y954Z

object_name: rectal cancer


subject: UNII:6ZA31Y954Z

object_name: Childhood Rectal Carcinoma


subject: UNII:6ZA31Y954Z

object_name: renal carcinoma


subject: UNII:6ZA31Y954Z

object_name: kidney neoplasm


subject: UNII:6ZA31Y954Z

object_name: kidney cancer


subject: UNII:6ZA31Y954Z

object_name: Stomach cancer


subject: UNII:6ZA31Y954Z

object_name: gastric cancer


subject: UNII:6ZA31Y954Z

object_name: thyroid tumor


subject: UNII:6ZA31Y954Z

object_name: thyroid gland carcinoma


subject: UNII:6ZA31Y954Z

object_name: thyroid cancer


subject: UNII:6ZA31Y954Z

object_name: Neck Carcinoma


subject: UNII:6ZA31Y954Z

object_name: head and neck neoplasm


subject: UNII:6ZA31Y954Z

object_name: head and neck cancer


subject: UNII:6ZA31Y954Z

object_name: pancreatic neoplasm


subject: UNII:6ZA31Y954Z

object_name: exocrine pancreatic carcinoma


subject: UNII:6ZA31Y954Z

object_name: malignant pancreatic neoplasm


subject: UNII:6ZA31Y954Z

object_name: malignant testicular germ cell tumor


subject: UNII:6ZA31Y954Z

object_name: neoplasm of testis